2019原著論文

Iwase M, Fujita K, Nishimura Y, Seba N, Masuo Y, Ishida H, Kato Y, Kiuchi Y. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38. Cancer Chemother Pharmacol 83(5): 993-998, 2019. ※昭和大学グループが中心の共同研究